These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

230 related articles for article (PubMed ID: 14659906)

  • 21. Characterization of HIV-1 Gag-specific T cell responses in chronically infected Indian population.
    Kaushik S; Vajpayee M; Wig N; Seth P
    Clin Exp Immunol; 2005 Nov; 142(2):388-97. PubMed ID: 16232229
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Analyzing T-cell responses to cytomegalovirus by cytokine flow cytometry.
    Maecker HT; Maino VC
    Hum Immunol; 2004 May; 65(5):493-9. PubMed ID: 15172449
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Interferon-gamma ELISPOT assay for the quantitative measurement of antigen-specific murine CD8+ T-cells.
    Cole GA
    Methods Mol Biol; 2005; 302():191-204. PubMed ID: 15937353
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A vaccinia-based elispot assay for detection of CD8+ T cells from HIV-1 infected children.
    Buseyne F; Catteau A; Scott-Algara D; Corre B; Porrot F; Rouzioux C; Blanche S; Rivière Y
    J Immunol Methods; 2005 Mar; 298(1-2):105-18. PubMed ID: 15847801
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Quantifying HIV-1-specific CD8 (+) T-cell responses using ELISPOT and cytokine flow cytometry.
    Shacklett BL; Critchfield JW; Lemongello D
    Methods Mol Biol; 2009; 485():359-74. PubMed ID: 19020837
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Proliferative, IFNgamma and IL-2-producing T-cell responses to HIV-2 in untreated HIV-2 infection.
    Alatrakchi N; Damond F; Matheron S; Beretta-Tempelhoff S; Campa P; Carcelain G; Brun-Vezinet F; Autran B;
    AIDS; 2006 Jan; 20(1):29-34. PubMed ID: 16327316
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Direct measurement of CD4+ and CD8+ T-cell responses to CMV in HIV-1-infected subjects.
    Komanduri KV; Donahoe SM; Moretto WJ; Schmidt DK; Gillespie G; Ogg GS; Roederer M; Nixon DF; McCune JM
    Virology; 2001 Jan; 279(2):459-70. PubMed ID: 11162802
    [TBL] [Abstract][Full Text] [Related]  

  • 28. An optimized IFN-γ ELISpot assay for the sensitive and standardized monitoring of CMV protein-reactive effector cells of cell-mediated immunity.
    Barabas S; Spindler T; Kiener R; Tonar C; Lugner T; Batzilla J; Bendfeldt H; Rascle A; Asbach B; Wagner R; Deml L
    BMC Immunol; 2017 Mar; 18(1):14. PubMed ID: 28270111
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Infrequent detection of HIV-1-specific, but not cytomegalovirus-specific, CD8(+) T cell responses in young HIV-1-infected infants.
    Scott ZA; Chadwick EG; Gibson LL; Catalina MD; McManus MM; Yogev R; Palumbo P; Sullivan JL; Britto P; Gay H; Luzuriaga K;
    J Immunol; 2001 Dec; 167(12):7134-40. PubMed ID: 11739536
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Tuberculosis antigen-specific immune responses can be detected using enzyme-linked immunospot technology in human immunodeficiency virus (HIV)-1 patients with advanced disease.
    Clark SA; Martin SL; Pozniak A; Steel A; Ward B; Dunning J; Henderson DC; Nelson M; Gazzard B; Kelleher P
    Clin Exp Immunol; 2007 Nov; 150(2):238-44. PubMed ID: 17672869
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Human immunodeficiency virus-specific gamma interferon enzyme-linked immunospot assay responses targeting specific regions of the proteome during primary subtype C infection are poor predictors of the course of viremia and set point.
    Gray CM; Mlotshwa M; Riou C; Mathebula T; de Assis Rosa D; Mashishi T; Seoighe C; Ngandu N; van Loggerenberg F; Morris L; Mlisana K; Williamson C; Karim SA;
    J Virol; 2009 Jan; 83(1):470-8. PubMed ID: 18945774
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Flow cytometric determination of intracellular or secreted IFNgamma for the quantification of antigen reactive T cells.
    Asemissen AM; Nagorsen D; Keilholz U; Letsch A; Schmittel A; Thiel E; Scheibenbogen C
    J Immunol Methods; 2001 May; 251(1-2):101-8. PubMed ID: 11292486
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Evaluation of the interlaboratory concordance in quantification of human immunodeficiency virus-specific T cells with a gamma interferon enzyme-linked immunospot assay.
    Samri A; Durier C; Urrutia A; Sanchez I; Gahery-Segard H; Imbart S; Sinet M; Tartour E; Aboulker JP; Autran B; Venet A;
    Clin Vaccine Immunol; 2006 Jun; 13(6):684-97. PubMed ID: 16760328
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Vaccinia assay for the rapid detection of functional HIV-specific CD8+ cytotoxic T lymphocytes.
    Xu J; Lori F; Lisziewicz J
    J Immunol Methods; 2003 May; 276(1-2):45-57. PubMed ID: 12738358
    [TBL] [Abstract][Full Text] [Related]  

  • 35. High background in ELISpot assays is associated with elevated levels of immune activation in HIV-1-seronegative individuals in Nairobi.
    Liu AY; De Rosa SC; Guthrie BL; Choi RY; Kerubo-Bosire R; Richardson BA; Kiarie J; Farquhar C; Lohman-Payne B
    Immun Inflamm Dis; 2018 Sep; 6(3):392-401. PubMed ID: 29974672
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Improving the sensitivity of the ELISPOT analyses of antigen-specific cellular immune responses in rhesus macaques.
    Sastry KJ; Nehete PN; Nehete B
    Methods Mol Biol; 2005; 302():153-66. PubMed ID: 15937350
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Detection of vaccinia virus-specific IFNγ and IL-10 secretion from human PBMCs and CD8⁺ T cells by ELISPOT.
    Umlauf BJ; Pinsky NA; Ovsyannikova IG; Poland GA
    Methods Mol Biol; 2012; 792():199-218. PubMed ID: 21956512
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Validation of a HLA-A2 tetramer flow cytometric method, IFNgamma real time RT-PCR, and IFNgamma ELISPOT for detection of immunologic response to gp100 and MelanA/MART-1 in melanoma patients.
    Xu Y; Theobald V; Sung C; DePalma K; Atwater L; Seiger K; Perricone MA; Richards SM
    J Transl Med; 2008 Oct; 6():61. PubMed ID: 18945350
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Rapid quantification of SIV-specific CD8 T cell responses with recombinant vaccinia virus ELISPOT or cytokine flow cytometry.
    Moretto WJ; Drohan LA; Nixon DF
    AIDS; 2000 Nov; 14(16):2625-7. PubMed ID: 11101083
    [No Abstract]   [Full Text] [Related]  

  • 40. A dual color ELISPOT method for the simultaneous detection of IL-2 and IFN-gamma HIV-specific immune responses.
    Boulet S; Ndongala ML; Peretz Y; Boisvert MP; Boulassel MR; Tremblay C; Routy JP; Sekaly RP; Bernard NF
    J Immunol Methods; 2007 Mar; 320(1-2):18-29. PubMed ID: 17222422
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.